_version_ 1785099233222721536
author Narvel, Hiba
Vegivinti, Charan
Vikash, Sindhu
Bazarbachi, Abdul Hamid
Pradhan, Kith
Wang, Shuai
Hammami, M. Bakri
Narvel, Nida
Yakkali, Shreyas
Ansari, Shehbaz
Nabi, Adnan Gulam
Mohammed, Turab
Mantzaris, Ioannis
Konopleva, Marina
Goldfinger, Mendel
Gritsman, Kira
Cooper, Dennis
Shastri, Aditi
Shah, Nishi
Kornblum, Noah
Verma, Amit
Sica, R. Alejandro
author_facet Narvel, Hiba
Vegivinti, Charan
Vikash, Sindhu
Bazarbachi, Abdul Hamid
Pradhan, Kith
Wang, Shuai
Hammami, M. Bakri
Narvel, Nida
Yakkali, Shreyas
Ansari, Shehbaz
Nabi, Adnan Gulam
Mohammed, Turab
Mantzaris, Ioannis
Konopleva, Marina
Goldfinger, Mendel
Gritsman, Kira
Cooper, Dennis
Shastri, Aditi
Shah, Nishi
Kornblum, Noah
Verma, Amit
Sica, R. Alejandro
author_sort Narvel, Hiba
collection PubMed
description
format Online
Article
Text
id pubmed-10468403
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104684032023-09-01 Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort Narvel, Hiba Vegivinti, Charan Vikash, Sindhu Bazarbachi, Abdul Hamid Pradhan, Kith Wang, Shuai Hammami, M. Bakri Narvel, Nida Yakkali, Shreyas Ansari, Shehbaz Nabi, Adnan Gulam Mohammed, Turab Mantzaris, Ioannis Konopleva, Marina Goldfinger, Mendel Gritsman, Kira Cooper, Dennis Shastri, Aditi Shah, Nishi Kornblum, Noah Verma, Amit Sica, R. Alejandro Stem Cell Investig Letter to the Editor AME Publishing Company 2023-08-24 /pmc/articles/PMC10468403/ /pubmed/37662874 http://dx.doi.org/10.21037/sci-2023-021 Text en 2023 Stem Cell Investigation. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Narvel, Hiba
Vegivinti, Charan
Vikash, Sindhu
Bazarbachi, Abdul Hamid
Pradhan, Kith
Wang, Shuai
Hammami, M. Bakri
Narvel, Nida
Yakkali, Shreyas
Ansari, Shehbaz
Nabi, Adnan Gulam
Mohammed, Turab
Mantzaris, Ioannis
Konopleva, Marina
Goldfinger, Mendel
Gritsman, Kira
Cooper, Dennis
Shastri, Aditi
Shah, Nishi
Kornblum, Noah
Verma, Amit
Sica, R. Alejandro
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title_full Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title_fullStr Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title_full_unstemmed Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title_short Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
title_sort primary central nervous system lymphoma: treatment access and outcomes in hiv positive patients in a minority rich cohort
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468403/
https://www.ncbi.nlm.nih.gov/pubmed/37662874
http://dx.doi.org/10.21037/sci-2023-021
work_keys_str_mv AT narvelhiba primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT vegivinticharan primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT vikashsindhu primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT bazarbachiabdulhamid primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT pradhankith primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT wangshuai primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT hammamimbakri primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT narvelnida primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT yakkalishreyas primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT ansarishehbaz primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT nabiadnangulam primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT mohammedturab primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT mantzarisioannis primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT konoplevamarina primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT goldfingermendel primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT gritsmankira primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT cooperdennis primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT shastriaditi primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT shahnishi primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT kornblumnoah primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT vermaamit primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort
AT sicaralejandro primarycentralnervoussystemlymphomatreatmentaccessandoutcomesinhivpositivepatientsinaminorityrichcohort